AsiaNet Daily Summary, Press Releases for Monday, September 10

SYDNEY--10 Sep--AsiaNet/InfoQuest


HIV TREATMENT...
LOS ANGELES: AIDS Healthcare Foundation (AHF) Monday called on Gilead Sciences and Merck to immediately register and distribute the three-in-one, once daily lifesaving HIV treatment, Atripla, in developing countries.
http://www.aidshealth.org

TICKETMASTER APPOINTS...
MELBOURNE: Ticketmaster, the world's leading ticketing company, has appointed Matt Huxley Chief Operating Officer for Australia and New Zealand.
http://www.ticketmaster.com

MOBILE WIMAX...
FREMONT, Calif. and BEIJING: ApaceWave Technologies, a developer of high-performance baseband processors for the global WiMAX industry, Monday announced its APW-2000 Mobile Station System-on-a-Chip (SoC) at the WiMAX Summit in Beijing.
http://www.apacewave.com

JETSTAR LAUNCHES...
MELBOURNE: Australia's low fares airline Jetstar has launched value based long haul international services into Malaysia, offering direct flights between Kuala Lumpur and Sydney 3 times weekly.

HIV DRUG...
HILTON HEAD ISLAND, S.C.: At 3:21 PM Sunday, Dr. Roger Kenneth Hershline PhD MD, Chairman and Founder of CureHIV.us, agreed to act as a conduit to provide samples of Global Humanceuticals, Inc's., new extremely effective, safe and stable drug candidate to profit, non-profit, academic, government, non-government, U.S. and foreign institutions, organizations, and corporations, under mutual agreements, contracts or partnerships, to spur theoretical, objective, mechanistic, developmental or clinical research.
http://www.curehiv.us

NEW DESTINATION...
MELBOURNE: Jetstar Saturday commenced value based, international long haul operations between Osaka and Cairns, the gateway to tropical Australia, representing the start of an initial four times weekly direct service and the second stage of Jetstars network expansion into the Kansai Region and greater western Japan.

ISTITHMAR COMPLETES...
DUBAI: Istithmar Friday announced the completion of its acquisition of luxury retailer Barneys New York at a purchase price of US$942.3 million.
http://www.istithmar.ae

OPEC OUTPUT...
LONDON: OPEC crude production fell by 40,000 barrels per day (b/d) in August, to 30.46 million b/d from 30.5 million b/d in July, mainly because of lower exports from Iraq, a Platts survey showed September 7.
http://www.platts.com
http://www.mcgraw-hill.com

STOCK TRADING...
PALM BEACH, Fla.: Real Logic, Inc. Friday issued a statement saying the company's stock initiated full trading status.
http://www.reallogic.net

BUSINESSWOMEN CONNECT...
WASHINGTON: In an effort to build greater connections between Chinese and African women, Vital Voices Global Partnership, with the support of Standard Chartered Bank, will bring 18 African women to Shanghai, China over September 9-12, 2007, for a an intensive three-day program to develop partnerships that will further economic development and encourage trade while fostering
accountability and encouraging social responsibility.

BENCHMARK NOTES...
WASHINGTON: Fannie Mae will issue new 3-year Benchmark Notes which will be priced on Sept 11, 2007 and re-open 5-Year Benchmark Notes which will also priced on the same day.
http://www.fanniemae.com

SPIRIT CEO...
WICHITA, Kan.: Spirit AeroSystems, Inc. President and Chief Executive Officer Jeff Turner will speak at the Morgan Stanley CEOs Unplugged Conference on Tuesday, Sept. 11 at about 12:30 p.m. Eastern Time.
http://www.spiritaero.com/investor.aspx

CHRYSLER APPOINTS...
AUBURN HILLS, Mich.: Chrysler LLC Friday named Philip Murtaugh as CEO -- Asia Operations.
http://media.chrysler.com
http://www.chrysler.com
http://cgmedia.chrysler.com

FANNIE MAE...
WASHINGTON, D.C.: Fannie Mae will redeem the principal amount of three securities issues amounting to a total of US$150 million on Sept 17, 2007 at a redemption price equal to 100 percent of the principal amount redeemed plus accrued interest.
http://www.fanniemae.com

AsiaNet is a consortium of leading news agencies distributing unedited, translated news releases for worldwide clients. Visit www.asianetnews.net for full-text versions.

ข่าวGilead Sciences+o:asnวันนี้

GILEAD LAUNCHES GLOBAL ALL4LIVER GRANT PROGRAM TO HELP ACHIEVE THE WORLD HEALTH ORGANIZATION'S GOAL OF VIRAL HEPATITIS ELIMINATION BY 2030

- Gilead expands the ALL4LIVER Grant, Providing Grant Funding to Organizations in Africa, South America, Asia and Oceania, Europe and North America - Themed 'Test. Link. Prioritize', the Grant Program will Target Projects Focusing on Viral Hepatitis Elimination by 2030 - Gilead Sciences, Inc. (Nasdaq: GILD) today announced the launch of the 2023 Gilead ALL4LIVER Grant, a grant program with the theme of 'Test. Link. Prioritize', designed to support innovative projects that drive testing, improve

Results are part of the first Asia Pacifi... PEOPLE LIVING WITH HIV AND INDIVIDUALS AT-RISK EXPERIENCED DISRUPTION TO HIV CARE IN THAILAND: SURVEY — Results are part of the first Asia Pacific-wide su...

Hetero Enters Into a Licensing Agreement With Gilead Sciences, Inc. for the Manufacturing and Distribution of "Remdesivir" in 127 Countries, Including India, for COVID-19

Hetero, one of India's leading generic pharmaceutical companies and the world's largest producer of anti-retroviral drugs,...

Hetero ลงนามในสัญญาอนุญาตให้ใช้สิทธิกับ Gilead Sciences เพื่อผลิตและจัดจำหน่ายยาต้านโควิด-19 “Remdesivir” ใน 127 ประเทศ รวมถึงอินเดีย

Hetero ผู้ผลิตยาสามัญชั้นแนวหน้าของอินเดียและผู้ผลิตยาต้านรีโทรไวรัสรายใหญ่ที่สุดของโลก ประกาศว่า ทางบริษัทได้ลงนามในสัญญาอนุญาตให้ใช้สิทธิกับ Gilead Sciences, Inc. ...

Cipla Enters Into a Licensing Agreement With Gilead to Expand Access to COVID-19 Treatment

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (and hereafter referred to as "Cipla") today announced that it has signed a non-exclusive licensing agreement with Gilead Sciences, Inc. for the manufacturing and...

Cipla บรรลุข้อตกลงอนุญาตใช้สิทธิกับ Gilead มุ่งขยายการเข้าถึงการรักษาโรคโควิด-19

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (และกล่าวถึงในที่นี้ว่า “Cipla”) ประกาศในวันนี้ว่า บริษัทได้ลงนามในข้อตกลงอนุญาตใช้สิทธิโดยไม่จำกัดแต่เพียงผู้เดียวกับ Gilead Sciences, Inc. เพื่อผลิต...

กว่าหมื่นรายชื่อเรียกร้องบริษัทยาหยุดผูกขาดตลาดขายยาไวรัสตับอักเสบซีเม็ดละสามหมื่น

คนไทยกว่าหมื่นคนร่วมลงชื่อผ่าน Change.org/StopGilead เรียกร้องบริษัทยากิลิแอด (Gilead Sciences, Inc.) ผู้คิดค้นและผลิตยาไวรัสตับอักเสบซีที่มีประสิทธิภาพสูงสุดในท้องตลาดขณะนี้ ให้หยุดผูกขาดตลาดและเลิกขายยาราคาเม็ดละ 3...

Janssen Announces Collaboration with Gilead to Develop PREZISTA(R)-based Single-tablet Regimen for the Treatment of People Living with HIV

Two Companies to also Collaborate on the Further Development of Complera(R), Marketed as Eviplera(R) in the European Union Janssen R&D Ireland (Janssen) announced...

Janssen Submits Marketing Authorisation Application to European Medicines Agency for a Fixed-Dose Combination Tablet of HIV-1 Medicine Darunavir with Cobicistat

Janssen-Cilag International NV (Janssen), today announced it has submitted a Marketing Authorisation Application to the European Medicines...

สรุปข่าวเอเชียเน็ทประจำวันจันทร์ที่ 10 กันยายน 2550

การรักษาโรคเอดส์ ลอสแองเจลิส: มูลนิธิดูแลสุขภาพผู้ป่วยเอดส์ (AHF) เรียกร้องให้บริษัท จีลีด ไซแอนเซส (Gilead Sciences) และ เมอร์ค (Merck) เร่งจดทะเบียนในทันที และจัดจำหน่ายยาอาตริพลา (Atripla) ซึ่งเป็นยารักษาโรคเอดส์แบบ 3 in 1 และรับประทานเพียงวันละ...